Antipsychotic use in youth without psychosis a double-edged sword

JAMA Psychiatry

Volumn 72, Issue 9, 2015, Pages 859-860

  Correll, Christoph U ^a,b,c,d   Blader, Joseph C ^e  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AGGRESSION; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; DEPRESSION; DRUG USE; EDITORIAL; HUMAN; PSYCHOSIS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CLINICAL PRACTICE; DEPRESSIVE DISORDER; FEMALE; INTELLECTUAL DISABILITY; MALE; PSYCHOTHERAPY; TRENDS;

ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; DEPRESSIVE DISORDER; FEMALE; HUMANS; INTELLECTUAL DISABILITY; MALE; PRACTICE PATTERNS, PHYSICIANS'; PSYCHOTHERAPY;

EID: 84940970089     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.0632     Document Type: Editorial

References (8)

1. Olfson M, Blanco C, Liu SM, Wang S, Correll CU. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry. 2012;69(12): 1247-1256.
2. Scotto Rosato N, Correll CU, Pappadopulos E, et al. Treatment of maladaptive aggression in youth: CERT guidelines II: Treatments and ongoing management. Pediatrics. 2012;129(6):e1577-e1586. doi:10.1542/peds.2010-1361.
3. Lesh TA, Tanase C, Geib BR, et al. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. JAMA Psychiatry. 2015;72(3):226-234.
4. Olfson M, King M, Schoenbaum M. Treatment of young people with antipsychotic medications in the United States [published online July 1, 2015]. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2015.0500.
5. Blader JC, Schooler NR, Jensen PS, Pliszka SR, Kafantaris V. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy. Am J Psychiatry. 2009; 166(12):1392-1401.
6. Hirota T, Schwartz S, Correll CU. Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: A systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy. J AmAcad Child Adolesc Psychiatry. 2014; 53(2):153-173.
7. Schwartz S, Correll CU. Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: Results from a comprehensive meta-analysis and metaregression. J Am Acad Child Adolesc Psychiatry. 2014;53(2):174-187.
8. Constantine R, Bengtson MA, Murphy T, et al. Impact of the Florida Medicaid prior-authorization program on use of antipsychotics by children under age six. Psychiatr Serv. 2012;63(12):1257-1260.